Global Aesthetic Injectables Market, By Type (Wrinkle Relaxers, Dermal Fillers), Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Other) – Industry Trends and Forecast to 2029
Market Analysis and Size
In recent years, the cosmetic industry is found to be booming in the current decade and has undergone an estimated three-fold increase in turnover over the last few decades. In particular, there has been an increase in the total number of non-surgical therapies, such as injections of wrinkle relaxers and dermal fillers.
- Data Bridge Market Research analyses that the aesthetic injectables market is expected to grow at CAGR of 15.63% during the forecast period. Due to the growing usage of aesthetic injectables for aesthetic procedures such as facial lines, wrinkles on the forehead, and lip lines, the “Facial Line” of applicaton segment led the industry.
Market Definition
Aesthetic injectables, also known as “soft tissue fillers,” diminish facial wrinkles by filling in the area under the skin. A gel-like substance is injected into certain areas of the face, restoring volume and “smoothing out” fine lines, wrinkles, and folds in the skin. Dermal fillers may also be used to plump up the lips.
Aesthetic Injectables Market Dynamics
Drivers
-
Increasing aesthetic consciousness among people
Young and beautiful are not just words anymore it’s like a trend nowadays and people are getting aware about these facts and good looks are not only for a good personality anymore many people rely on their young looks to make a living nowadays and it is driving the market.
-
Rising number of cosmetic procedure
Nowadays for every skin problem there are many new treatments to make you look young and beautiful and people are paying high amounts for these procedure and its rising market value and driving the market
Additionally, the, Growing prevalence of cost effective facial injectable and increasing geriatric population affect the aesthetic injectables market.
Opportunities
Furthermore, ease of recovery while staying at home and rising awareness about skincare will further expand the aesthetic injectables market's growth rate in the future.
Restraints/Challenges
On the other hand, unavailability of reimbursement policies of cosmetic procedure is expected to obstruct market growth. Also, increasing risk associated with the available aesthetic injectable is projected to challenge the aesthetic injectables market in the forecast period of 2022-2029.
This aesthetic injectables market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the aesthetic injectables market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID -19 Impact on Aesthetic Injectables Market
Because of the current COVID-19 pandemic, people are spending more time on video calls. Known as the 'Zoom Boom,' a growing number of people are becoming more conscious of their physical presence. This has resulted in a rise in cosmetic surgery demand, with Botox being one of the most common treatments. Cosmetic procedures are also becoming more common with patients due to the ease with which they can heal while living at home. As a result, after the pandemic, the demand for aesthetic injectables exploded. .
Global Aesthetic Injectables Market Scope
The aesthetic injectables market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Wrinkle relaxers
- Dermal fillers
On the basis of type, the aesthetic injectables market is segmented into wrinkle relaxers and dermal fillers. Wrinkle relaxers are further segmented into botulinum toxin. Dermal fillers are further segmented into collagen, hyaluronic acid, fat injection, polylactic acid, polymethyl-methacrylate microspheres (PMMA), calcium hydroxylapatite and other dermal fillers. Other dermal filler is further segmented into polyalkylimide.
Application
- Facial line correction
- Lip augmentation
- Face lift
- Acne scar treatment
- Lipoatrophy treatment
- Other
On the basis of application, the aesthetic injectables market is segmented into facial line correction, lip augmentation, face lift, acne scar treatment, lipoatrophy treatment and other.
Aesthetic Injectables Market Regional Analysis/Insights
The aesthetic injectables market is analysed and market size insights and trends are provided by country, type and application as referenced above.
The countries covered in the aesthetic injectables market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the aesthetic injectables market because of the increasing demand for minimally invasive surgery among population within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the growing awareness about women’s health and growing healthcare expenditure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The aesthetic injectables market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for aesthetic injectables market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the aesthetic injectables market. The data is available for historic period 2010-2020.
Competitive Landscape and Aesthetic Injectables Market Share Analysis
The aesthetic injectables market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to aesthetic injectables market.
Some of the major players operating in the aesthetic injectables market are Luminera, ALLERGAN, Anika Therapeutics, Inc., Medytox, Merz Pharma, Nestlé Skin Health, Galderma Laboratories, L.P.; Sinclair Pharma, Suneva Medical., Teoxane, Advanced Dermatology and Cosmetic Surgery, Bausch Health, Sanofi, Ipsen Pharma, Integra LifeSciences Corporation, FibroGen, Inc., Medical Devices Business Services, Inc., DR. Korman., Shanghai Fosun Pharmaceutical(Group)Co., Ltd. and Cynosure LLC among others.
SKU-